Clinical trials: Tularemia
Tularaemia
Phase II Tularemia Vaccine Comparison
The purpose of this study is to compare 2 experimental vaccines that could provide protection from the disease, tularemia. This research will compare the ability of the vaccines to cause the body to develop an immune (protective)…
- Trial name
- NCT01150695
- Testing
- Undiluted Francisella tularensis live attenuated vaccine
- Where
- 5 sites in United States
- Volunteers
- 228 people, healthy volunteers welcome
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Tularemia
FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)
The purpose of this study is to evaluate the safety and immunogenicity of the tularemia vaccine, live, attenuated, NDBR 101, Lot 4, and collect data on the incidence of occupational tularemia infection in vaccinated personnel.
- Trial name
- NDBR (NCT03867162)
- Testing
- Live Attenuated Tularemia Vaccine
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- U.S. Army Medical Research and Development Command
Tularemia
Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine
- Trial name
- NCT00584844
- Testing
- Live F tularensis Vaccine
- Where
- United States
- Volunteers
- 484 people, healthy volunteers welcome
- Sponsor
- U.S. Army Medical Research and Development Command
Leptospirosis, Hepatitis E Virus Infection
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
Human leptospirosis is a zoonotic disease caused by bacteria of the genus Leptospira. Due to its frequent inapparent course or mild severity with unspecific symptoms and limited availability of diagnostic laboratories the…
- Conditions
- Leptospirosis, Hepatitis E Virus Infection, Tularemia
- Trial name
- NCT05300425
- Testing
- Blood sample collection, Data collection
- Where
- 2 sites in Switzerland
- Volunteers
- 258 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Tularemia
Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine
- Trial name
- NCT00787826
- Testing
- Live Francisella Tularensis Vaccine
- Where
- United States
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- U.S. Army Medical Research and Development Command